AAAAAA

   
Results: 1-6 |
Results: 6

Authors: Rupp, S Rehm, S Tempelhof, S Seil, R
Citation: S. Rupp et al., Mid-term results after arthroscopic subacromial decompression (ASD) with special focus on the bias due to an application to social insurance for pension, UNFALLCHIRU, 104(10), 2001, pp. 961-964

Authors: Waalkes, MP Rehm, S Cherian, MG
Citation: Mp. Waalkes et al., Repeated cadmium exposures enhance the malignant progression of ensuing tumors in rats, TOXICOL SCI, 54(1), 2000, pp. 110-120

Authors: Bugelski, PJ Herzyk, DJ Rehm, S Harmsen, AG Gore, EV Williams, DM Maleeff, BE Badger, AM Truneh, A O'Brien, SR Macia, RA Wier, PJ Morgan, DG Hart, TK
Citation: Pj. Bugelski et al., Preclinical development of keliximab, a Primatized (TM) anti-CD4 monoclonal antibody, in human CD4 transgenic mice: characterization of the model andsafety studies, HUM EXP TOX, 19(4), 2000, pp. 230-243

Authors: Cardiff, RD Anver, MR Gusterson, BA Hennighausen, L Jensen, RA Merino, MJ Rehm, S Russo, J Tavassoli, FA Wakefield, LM Ward, JM Green, JE
Citation: Rd. Cardiff et al., The mammary pathology of genetically engineered mice: the consensus reportand recommendations from the Annapolis meeting, ONCOGENE, 19(8), 2000, pp. 968-988

Authors: Rehm, S
Citation: S. Rehm, Spontaneous testicular lesions in purpose-bred beagle dogs, TOX PATHOL, 28(6), 2000, pp. 782-787

Authors: Sellers, T O'Brien, S Gossett, K Gunning, M Boram, D Rehm, S Kerns, W
Citation: T. Sellers et al., Altered hemostasis in male rats following administration of the ACAT inhibitor SKF-99085, TOXICOL SCI, 46(1), 1998, pp. 151-154
Risultati: 1-6 |